A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age
Condition:   Avian InfluenzaInterventions:   Biological: aH5N1c;   Biological: PlaceboSponsors:   Seqirus;   Biomedical Advanced Research and Development AuthorityRecruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2016 Category: Research Source Type: clinical trials

A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age
< b > Condition < /b > :   Avian Influenza < br/ > < b > Interventions < /b > :   Biological: aH5N1c;   Biological: Placebo < br/ > < b > Sponsors < /b > :   Seqirus;   Biomedical Advanced Research and Development Authority < br/ > < b > Recruiting < /b > - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2016 Category: Research Source Type: clinical trials

A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age
Condition:   Avian Influenza Interventions:   Biological: aH5N1c;   Biological: Placebo Sponsors:   Seqirus;   Biomedical Advanced Research and Development Authority Recruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2016 Category: Research Source Type: clinical trials

A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age
Condition:   Avian InfluenzaInterventions:   Biological: aH5N1c;   Biological: PlaceboSponsors:   Seqirus;   Biomedical Advanced Research and Development AuthorityRecruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2016 Category: Research Source Type: clinical trials

A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age
< b > Condition < /b > :   Avian Influenza < br/ > < b > Interventions < /b > :   Biological: aH5N1c;   Biological: Placebo < br/ > < b > Sponsors < /b > :   Seqirus;   Biomedical Advanced Research and Development Authority < br/ > < b > Recruiting < /b > - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2016 Category: Research Source Type: clinical trials

Safety and Immunogenicity of IVACFLU-A/H5N1 in Vietnamese Adult
Condition:   Influenza A/H5N1Interventions:   Biological: IVAC-H5N1-15ug;   Biological: IVAC-H5N1-30ug;   Biological: IVAC-placeboSponsors:   National Institute of Hygiene and Epidemiology, Vietnam;   PATH;   Institute of Vaccines and Medical Biologicals, VietnamRecruiting - verified June 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 19, 2016 Category: Research Source Type: clinical trials